Table 2.
Spearman correlation coefficients |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Variables | (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | (11) |
(1) Overall drug use improvement | 1.000 | 0.782c | 0.054b | 0.040a | 0.693c | 0.043a | 0.053b | 0.028 | −0.228c | 0.042a | 0.187c |
(2) Primary drug use improvement | 1.000 | 0.045a | 0.062c | 0.534c | 0.078c | 0.074c | 0.075c | −0.232c | 0.015 | 0.181c | |
(3) Percent of needs service matched | 1.000 | 0.176c | −0.030 | 0.086c | 0.056b | −0.115c | −0.053b | −0.033 | 0.166c | ||
(4) Treatment duration, per week | 1.000 | −0.048b | −0.033 | −0.024 | 0.264c | 0.184c | −0.531c | 0.055b | |||
(5) Past-year peak level of drug use | 1.000 | −0.047b | 0.020 | 0.254c | −0.360c | 0.060c | 0.149c | ||||
(6) Reduction from past-year peak use | 1.000 | 0.018 | −0.307c | 0.131c | 0.053b | 0.038a | |||||
(7) Female gender | 1.000 | −0.019 | −0.113c | −0.016 | 0.148c | ||||||
(8) Methadone modality | 1.000 | d | d | d | |||||||
(9) Non-methadone out-patient modality | 1.000 | d | d | ||||||||
(10) Short-term residential modality | 1.000 | d | |||||||||
(11) Long-term residential modality | 1.000 |
P < 0.05;
P < 0.01;
P < 0.001;
dummy variable, correlations not meaningful.